Acorda Therapeutics, Inc. – Strategy, SWOT and Corporate Finance Report

Acorda Therapeutics, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Acorda Therapeutics (Acorda or 'the company') is a commercial-stage biotechnology company. It is engaged in the development and marketing of therapies to help restore function in persons with spinal cord injury, multiple sclerosis and related conditions of the central nervous system. The company also offers various pipeline products to neurological therapies including heart failure, migraine, Primary Sclerosing Cholangitis, MS, spinal cord injury and various other disorders. Acorda's product portfolio are marketed under Zanaflex, Ampyra or Fampyra (dalfampridine); Inbrija ,BTT1023,SYN120,RHLGM22 and GGF2..It develop additional inhaled medicines for both systemic and pulmonary conditions.The company primarily operates in the US, where it is headquartered in Ardsley, New York.

Scope

– Detailed information on Acorda Therapeutics, Inc. required for business and competitor intelligence needs

– A study of the major internal and external factors affecting Acorda Therapeutics, Inc. in the form of a SWOT analysis

– An in-depth view of the business model of Acorda Therapeutics, Inc. including a breakdown and examination of key business segments

– Intelligence on Acorda Therapeutics, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

– News about Acorda Therapeutics, Inc., such as business expansion, restructuring, and contract wins

– Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Acorda Therapeutics, Inc. and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess Acorda Therapeutics, Inc. as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on Acorda Therapeutics, Inc.'s business structure, strategy and prospects.

Table of Contents

Table of Contents

Company Snapshot

Acorda Therapeutics, Inc.: Company Overview

Acorda Therapeutics, Inc.: Overview and Key Facts

Acorda Therapeutics, Inc.: Overview

Acorda Therapeutics, Inc.: Key Facts

Acorda Therapeutics, Inc.: Key Employees

Acorda Therapeutics, Inc.: Key Employee Biographies

Acorda Therapeutics, Inc.: Major Products and Services

Acorda Therapeutics, Inc.: Company History

Acorda Therapeutics, Inc.: Management Statement

Acorda Therapeutics, Inc.: Locations and Subsidiaries

Acorda Therapeutics, Inc.: Key Competitors

Acorda Therapeutics, Inc.: Company Analysis

Acorda Therapeutics, Inc.: Business Description

Acorda Therapeutics, Inc.: SWOT Analysis

Acorda Therapeutics, Inc.: SWOT Overview

Acorda Therapeutics, Inc.: Strengths

Acorda Therapeutics, Inc.: Weaknesses

Acorda Therapeutics, Inc.: Opportunities

Acorda Therapeutics, Inc.: Threats

Acorda Therapeutics, Inc.: Corporate Financial Deals Activity

Acorda Therapeutics, Inc.: Financial Deals Overview

Acorda Therapeutics, Inc.: Top Deals 2017 - 2021YTD*

Acorda Therapeutics, Inc.: Advisors

Acorda Therapeutics, Inc.: Top Legal Advisors

Acorda Therapeutics, Inc.: Top Financial Advisors

Acorda Therapeutics, Inc.: Capital Raising

Acorda Therapeutics, Inc.: Divestments

Acorda Therapeutics, Inc.: Private Equity and Ownership

Acorda Therapeutics, Inc.: Recent Developments

Acorda Therapeutics, Inc.: News and Events Summary

Acorda Therapeutics, Inc.: Corporate Governance

Acorda Therapeutics, Inc.: Financial Performance

Acorda Therapeutics, Inc.: Regulatory and Legal Events

Acorda Therapeutics, Inc.: Research & Development

Acorda Therapeutics, Inc.: Strategy and Operations

Appendix

Contact Us

Methodology

About MarketLine

List of Tables

List of Tables

Table 1: Acorda Therapeutics, Inc.: Key Facts

Table 2: Acorda Therapeutics, Inc.: Key Employees

Table 3: Acorda Therapeutics, Inc.: Company History

Table 4: Acorda Therapeutics, Inc.: Locations and Subsidiaries

Table 5: Acorda Therapeutics, Inc.: Key Competitors

Table 6: Acorda Therapeutics, Inc.: Deal Activity by Deal Type – Volume (TTM*)

Table 7: Acorda Therapeutics, Inc.: Deal Activity by Deal Type – Volume (2017 – YTD*2021)

Table 8: Acorda Therapeutics, Inc.: Top Deals 2017 – 2021YTD*

Table 9: Acorda Therapeutics, Inc.: Legal Advisor Ranking by Value (US$m)

Table 10: Acorda Therapeutics, Inc.: Financial Advisor Ranking by Value (US$m)

Table 11: Acorda Therapeutics, Inc.: Capital Raising Volume and Value Trend (2017 – YTD*2021)

Table 12: Acorda Therapeutics, Inc.: Capital Raising by Deal Type (2017 – YTD*2021)

Table 13: Acorda Therapeutics, Inc.: Divestments Volume and Value Trend (2017 – YTD*2021)

Table 14: Acorda Therapeutics, Inc.: Private Equity and Ownership Volume and Value Trend (2017 – YTD*2021)

Table 15: Acorda Therapeutics, Inc.: Private Equity and Ownership Volume by Deal Type (2017 – YTD*2021)

Table 16: Acorda Therapeutics, Inc.: News and Events Summary

Table 17: Acorda Therapeutics, Inc.: Corporate Governance

Table 18: Acorda Therapeutics, Inc.: Financial Performance

Table 19: Acorda Therapeutics, Inc.: Regulatory and Legal Events

Table 20: Acorda Therapeutics, Inc.: Research & Development

Table 21: Acorda Therapeutics, Inc.: Strategy and Operations

List of Figures

List of Figures

Figure 1: Acorda Therapeutics, Inc.: Deal Activity by Deal Type – Volume (TTM*)

Figure 2: Acorda Therapeutics, Inc.: Deal Activity by Deal Type – Volume (2017 – YTD*2021)

Figure 3: Acorda Therapeutics, Inc.: Capital Raising Volume and Value Trend (2017 – YTD*2021)

Figure 4: Acorda Therapeutics, Inc.: Capital Raising by Deal Type (2017 – YTD*2021)

Figure 5: Acorda Therapeutics, Inc.: Divestments Volume and Value Trend (2017 – YTD*2021)

Figure 6: Acorda Therapeutics, Inc.: Private Equity and Ownership Volume and Value Trend (2017 – YTD*2021)

Figure 7: Acorda Therapeutics, Inc.: Private Equity and Ownership Volume by Deal Type (2017 – YTD*2021)

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2745

Saved reports